Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,349,800 shares, an increase of 51.1% from the March 15th total of 1,554,700 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ? days.

Ascentage Pharma Group International Price Performance

Shares of ASPHF opened at $5.83 on Friday. The company’s fifty day moving average price is $5.82 and its 200-day moving average price is $5.85. Ascentage Pharma Group International has a 1-year low of $5.42 and a 1-year high of $6.45.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.